HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $9 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.1%

Neg 0% Neu 89.1% Pos 0%

HC Wainwright & Co. analyst Yi Chen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $9 price target.

Comments

No comments yet. Be the first!